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1. Introduction
  Breast cancer is one of the most common malignancies 
for women, the incidence of which increases year by 
year in recent years, but the age of onset keeps dropping. 
Breast cancer often has distant metastases in bone, liver, 
lung and others, among which the incidence of bone 
metastasis is the highest. Breast cancer bone metastasis 
is a complex process involving multiple genes, factors 
and steps. The research on the occurrence and molecular 
mechanism of breast cancer bone metastasis remains a hot 
spot at present. Since Muller et al[1] firstly reported that 
chemokine receptor was associated with tumor metastasis, 
and more and more chemokine receptors have been 
found to be closely related to many processes of tumor 
development in the subsequent studies. The chemokines 
are cytokines with low molecular weight (8-10 kD) secreted 
by different kinds of cells. Their receptors are a kind of 
G-protein-coupled receptors containing 7 transmembrane 
domains which can express in different types of cells. The 
chemokines and their receptors play an important role in 
the tumor target migration process in bone marrow and 
other specific organs and tissues containing hematopoietic 
cells. The interaction of the chemokine in bone matrix and 
the receptor in breast cancer cell promotes the specific 
bone metastasis of breast cancer[2]. It has been found that 
CXCR4 is expressed in at least 23 kinds of tumors till now[3]. 
Numerous studies demonstrated that CXCR4 is closely 
associated with tumorigenesis and is highly expressed in 
human breast cancer cell, malignant breast tumor and 
distant metastasis[4]. This study analyzed the molecular 
structure and functional characteristics of CXCR4-the 
chemokine receptor related to breast cancer metastasis 
by bioinformatics method, providing theoretical basis for 
Objective: To analyze breast cancer bone metastasis related gene-CXCR4. Methods: This 
research screened breast cancer bone metastasis related genes by high-flux gene chip. Results: 
It was found that the expressions of 396 genes were different including 165 up-regulations 
and 231 down-regulations. The expression of chemokine receptor CXCR4 was obviously up-
regulated in the tissue with breast cancer bone metastasis. Compared with the tissue without bone 
metastasis, there was significant difference, which indicated that CXCR4 played a vital role in 
breast cancer bone metastasis. Conclusions:  The bioinformatics analysis of CXCR4 can provide 
a certain basis for the occurrence and diagnosis of breast cancer bone metastasis, target gene 
therapy and evaluation of prognosis.
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the targeted therapy and prognosis of breast cancer bone 
metastasis.    
2. Materials and methods
2.1. General data
  A total of 120 breast cancer patients were selected, who 
visited the Out-patient Department or hospitalized in 
our hospital from March, 2009 to December, 2011, and all 
received surgical treatment and were finally diagnosed by 
pathological examination. The patients were divided into 
experimental group with76 cases of bone metastasis and 
control group 44 cases without bone metastasis according 
to the detection results of the single photon emission 
computed tomography, CT and others. The group without 
bone metastasis did not have metastasis of other organs 
and lymph node through CT, B-ultrasonography and other 
detections. The age of the bone metastasis group was 28-
59 years with the average of 44.5 years. The age of the 
group without bone metastasis was 29-58 years old with the 
average of 43.5 years.
 
2.2. Methods
2.2.1. RNA extraction and probe preparation  
  The total RNA was extracted by Trizol one step method. The 
A260/A280 values of the RNA of two kinds of tissues were 
detected by the ultraviolet spectrophotometer. The agarose 
gel electrophoresis was performed to identify the quality 
of RNA. The cDNA probe with fluorescent labeling was 
synthesized and purified. Cy3 and Cy5 were used to label 
the control group and the experimental group, respectively. 
After ethanol precipitation, the probes were dissolved into 
the 20 毺L 5暳SSC+0.2% SDS hybridization solution. 
2.2.2. Chip hybridization
  The chips were pre-heated in the prehybridization buffer at 
55 曟. The labeled probes (Cy3/Cy5) were equally mixed. Then 
7.5 毺L 4暳 hybridization solutions, 15.0 毺L formamide and 
some sterile water were added to a total volume of 30.0 毺
L, with 5 min water bath at 95 曟 and 16 h incubation in the 
incubator at 42 曟 after blended and centrifuged. The chip 
was placed in the staining jar containing eluant (0.1% SSC) 
at 55 曟 in the rocking bed. After slowly weaved for 20 min 
at room temperature, the chip was repeatedly washed once, 
and then was air-dried at room temperature. 
2.2.3. Detection and analysis  
  The chip results were scanned by Agilent Microarray 
Scanner. The data were read by Feature Extraction Software 
10.7. Finally, Gene Spring Software11.0 was used to perform 
normalized processing, and the used algorithm was Lowess. 
2.2.4. Bioinformatics analysis of differentially expressed 
genes  
  The open reading frames (ORFs) of CXCR4 genes were 
found out by the online tool NCBI ORF Finder. The structure 
and function of human CXCR4 gene were analyzed by the 
online analysis softwares such as ProtParam, ProtScal, 
PSORTII and SOPMA. 
3. Results
3.1. Gene chip
  The signal points adjacent to slope rate 1.0 revealed no 
expression difference. The signal points whose slope rates 
were more than 2 and 0.5 were differentially expressed 
genes. The fluorescent labeled signal values were distributed 
in both sides of the symmetry axis, indicating that there 
were up-regulated genes and down-regulated genes (Figure 
1, 2). Compared with the control group, there were 396 
differentially expressed genes with 165 up-regulated genes 
and 231 down-regulated genes. 
Figure 1. Stacking chart of double-color fluorescent label for breast 
cancer bone metastasis and breast cancer without bone metastasis.
Green: down-regulated; red: up-regulated; yellow: similar intensity. 
 Heng-Hui Zhang et al./Asian Pacific Journal of Tropical Medicine (2013)732-738734
4            6           8           10         12         14         16          18          20
16
14
12
10
8
6
4
Figure 2. Scatter plot of gene chip hybridization signals.
 
3.2. Bioinformatics analysis of CXCR4
3.2.1. ORF analysis
 ORF is the normal nucleotide sequence of structure gene. 
The ORF from start codon to stop codon can encode a 
complete polypeptide chain, and there is no stop codon 
that can interrupt the translation in ORF. The identification 
of ORF is the precondition for proving that a new DNA 
sequence is the partial or full coding gene of a specific 
protein. The analysis results (Figure 3) demonstrated that the 
+2 ORF of CXCR4 was the longest with the length of 1 071 bp, 
encoding 356 amino acids.    
Figure 3. ORF analysis of human CXCR4 gene sequence.
 
3.2.2. Physicochemical property analysis of coding product
  The protein physicochemical properties include relative 
molecular weight, theoretical isoelectric point/atomic 
composition, instability coefficient, fat coefficient, general 
mean hydrophobicity and other physicochemical parameters.
  Physicochemical property of the coding product of CXCR4 
gene was predicted by the ExPASy online tool ProtParam. 
The amino acids composition of CXCR4 gene is shown in 
Figure 4. CXCR4 gene encoded 365 amino acids with most 
of Ile and Leu, accounting for 10.1% and 11.8%, respectively. 
The total residue number (Arg+Lys) of positive charge was 
31, while the total residue number (Asp+Glu) of negative 
charge was 26, with the theoretical molecular weight of 40.22 
kD and the theoretical isoelectric point of 8.61.  
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Figure 4. Amino acids composition of CDS sequence of CXCR4 gene.
3.2.3.  Hydrophobic / hydrophilic analysis of coding product
  The structure of protein determines its physiological 
function, and the hydrophobicity/hydrophilicity of amino 
acids can directly influence the structure and function of 
protein. The ExPASy ProtScal program was used to analyze 
the hydrophobicity of the encoding product of human CXCR4 
gene. The results are shown in Figure 5, and the x-axis and 
y-axis were amino acid sequence and amino acid scale. The 
hydrophobicity was stronger as the value was larger. Figure 
5 shows that the whole polypeptide chain expressed as 
hydrophobicity, therefore the CXCR4 was a water-insoluble 
protein.
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Figure 5. Hydrophobicity of the encoding product of CXCR4 gene.
3.2.4. Signal peptide prediction of the gene coding product
  Signal peptide is a short peptide sequence composed by 
3-60 amino acids. It is the identification signal that can 
transport the newly-synthesized protein to the destination, 
thus it can also be called target signal. SignalP 3.0 Server 
tool was utilized to predict the signal peptide of human 
CXCR4. As shown in Figure 6, the C score was the largest, S 
was steep, and Y value peaks between 68-70 amino acids. 
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It can be basically determined that signal peptide existed in 
the cleavage site. 
1.0
0.8
0.6
0.4
0.2
0.0
Sc
or
e
0              10             20              30              40             50             60             70
Position
Signalp-NN prediction (euk networks): Sequence
MSIPLPLLQIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQ
Figure 6. Signal peptide prediction of amino acids sequence of the 
CXCR4 coding products.
3.2.5. Subcellular localization
  The online prediction tool PSORTII was used to analyze the 
CXCR4 subcellular localization. The analytic results (Table 
1) indicated that this protein was probably located in the 
cellular membrane with the reliability of 56.5%. 
Table 1 
Prediction of subcellular localization of the CXCR4 encoding product.
Subcellular localization Possibility (%)
Cellular membrane 56.5
Endocytoplasmic reticulum 21.7
Vacuole   8.7
Golgi apparatus   4.3
Cellular nucleus   4.3
Mitochondria   4.3
   
3.2.6. Structure prediction
  SOPMA online analysis software was used to predict the 
secondary structure of CXCR4 encoding product (Figure 7). 
There were 173 毩-helixes (48.60%), 61 extended strands 
(17.13%), 10 毬-turns (2.81%) and 112 random coils (31.46%) 
in the CXCR4 structure.    
50               100              150              200             250               300
Figure 7. Secondary structure prediction of CXCR4 encoding product 
by SOPMA. 
  
  The analytic result of QuickPhyre online software indicated 
that the CXCR4 secondary structure had the greatest 
similarity with d1u19a protein. The sequence alignment 
between these two kinds of proteins is shown in Figure 8.  
  The three-dimensional structure analyzed by Phyre2 online 
software is shown in Figure 9. 
Figure 8. Sequence alignment between CXCR4 protein and d1u19a 
protein.
Figure 9. Three-dimensional structure of CXCR4.
3.2.7. CXCR4 protein function analyzed by Protfun online 
software
  Developed by the biological sequence analysis center 
of Technical University of Denmark, Protfun is a kind of 
software used to predict and analyze the structural function 
and classification of protein[5]. The analytic results of 
Protfun (Figure 10) indicated that CXCR4 protein belonged 
to non-enzyme. Functional category displayed that CXCR4 
had the function of transfer and combination (Prob=0.817, 
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Odds=1.992). GO category indicated that CXCR4 was a kind 
of structure protein.   
Figure 10. Prediction result of CXCR4 protein function.
3.2.8. Analysis of the structure functional domain
  The 7 transmembrane domains in CXCR4 structure 
functional domain were analyzed by SMART software (Figure 
11).  
0                             100                            200                            300
Transmembrane region Low complexity region
Figure 11. Functional domain distribution of CXCR4 protein structure. 
3.2.9. Analysis of phosphorylation sites
  Phosphorylation and dephosphorylation play important 
roles in many eukaryotic cells, including metabolism, cell 
division, signal transduction and others. The NetPhos2.0 
Server online software analytical tool was used to analyze 
the CXCR4 phosphorylation sites. The results (Figure 12) 
indicated that there were 15 serines located in the 27, 75, 
85, 182, 231, 233, 323, 328, 329, 342, 345, 348, 350, 351 and 
352 site, 2 threonines located in the 283 and 346 site and 4 
tyrosines located in the 16, 25, 161 and 188 site, which may 
be phosphorylated. 
Figure 12. Phosphorylation sites predicted by NetPhos2.0 Server.
3.2.10. Phylogenetic tree of CXCR4 encoding product
  The CXCR4 nucleotide and amino acids sequences were 
performed Blast homology search in NCBI database. The 
species with the homology higher than 96% were collected. 
The pair and multiple sequence alignments were performed 
using ClustalW, and the UPGMA phylogenetic tree was built 
by Phylogeny. Figure 13 indicated that the evolutionary 
distance between human CXCR4 and chimpanzee and 
Hylobates hoolock was the shortest with the closest genetic 
relationship, which was consistent with the zootaxy. The 
homology represented the genetic relationship among 
species and also reflected the importance of the structural 
stability of CXCR4 encoding product in different species on 
the function of organism.          
Presbytis francoisi
Pygathrix nemaeus
Presbytis entellus
Presbytis phayrei
Presbytis senex
Pygathrix avunculus
Rhinopithecus roxellanae
Nasalis larvatus
Colobus polykomos
Cercopithecus aethiops
Macaca fascicularis
Macaca mulatta
Papio anubis
Hylobates lar
Hylobates syndactylus
Nomascus leucogenys
Pan paniscus
Pan troglodytes verus
Homo sapiens
Hylobates hoolock
Gorilla gorilla gorilla
Pongo abelii
Pongo pygmaeus
Callithrix jacchus
Trichechus manatus latirostris
0.05         0.04        0.03         0.02          0.01        0.00
Figure 13. Phylogenetic tree of the CXCR4 encoding products of 
different species. 
 
4. Discussion
   The comparison of breast cancer bone metastasis tissue 
and breast cancer tissue without bone metastasis by gene 
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chip indicated that compared with the control group, the 
expressions of 396 genes had difference with 165 up-
regulations and 231 down-regulations in the experimental 
group. We cannot perform in-depth study one by one due 
to the numerous genes. This experiment and previous 
reports[6,7] demonstrated that CXCR4 is not expressed in 
normal mammary gland, and its expression amount in breast 
cancer bone metastasis tissue is obviously higher than the 
breast cancer tissue without bone metastasis. Therefore, 
we performed bioinformatics analysis of the CXCR4 gene 
in order to provide a certain basis for the study on the 
mechanism of breast cancer bone metastasis. 
  CXCR4 is a kind of protein containing 356 amino acids 
which is encoded by the gene separated from the cDNA of 
human monocyte by IL-8R gene probe. It is a kind of highly 
conserved G-protein-coupled transmembrane receptor[8,9]. 
It can cross the cellular membrane and transfer the signal in 
external environment to interior, having control action on the 
process related to tissue development such as cell growth, 
hormone secretion and light perception. Generally speaking, 
CXCR4 can help to activate immune system and stimulate 
cell motivation. When the signal activating receptor 
cannot be correctly modulated, CXCR4 would accelerate 
the aggravation and proliferation of cancer. CXCR4 is a 
chemokine receptor in GPCR gene family, and exists widely 
in the central nervous system and immunocytes. After 
combined with ligand stromal cell-derived factor-1 (SDF-1), 
CXCR4 can cause the migration of immunocytes and 
development of nervous system. CXCR4 is also the receptor 
of HIV virus entering T cell, and its ligand SDF-1 can block 
HIV infection. CXCR4 can down-regulate many signal 
pathways. CXCR4 binding SDF-1 can activate the signal 
pathway mediated by G protein and down-regulate ras and 
PI3 kinase. CXCR4 can activate AP-1 and chemokines to 
regulate gene transcription.
  Chemokine receptor CXCR4 is the specific receptor of 
chemokine stromal cell-derived factor-1(CXCL12), playing 
an important role in the formation and metastasis of human 
breast cancer[10]. The analysis of differentially expressed 
genes in this study indicated that the expression of CXCR4 
was obviously up-regulated, which is consistent with the 
previous reports[11-13] that the expression level of CXCR4 
obviously increased in many malignant tumor tissues 
including breast cancer. In vitro experiments CXCR4 binding 
its corresponding ligand SDF-1 can induce the metastasis 
of breast cancer cell, showing dosage effect relationship. 
Using anti-CXCR4 antibody or RNA interference technique 
to inhibit the expression of CXCR4 gene can inhibit the 
in vitro metastasis of breast cancer cells[14]. Some studies 
indicated that CXCR4 is the only receptor of chemokine 
SDF-1, which is expressed in many malignant tumor 
cells and leukemic cells[15-17] and participates in the 
metastasis of tumor[18]. An SL et al[19] studied the CXCR4 
expression in human breast cancer and precancerous 
lesion by immunohistochemistry, analyzed the relationship 
between the other clinicopathological parameters related 
to breast cancer, and concluded that CXCR4 may be the 
early molecular event of breast cancer, its expression in 
invasive breast cancer was related to the clinicopathological 
parameters of breast cancer advancement, and CXCR4 can 
be regarded as the diagnostic indicator of breast cancer and 
could be the new target for breast cancer treatment. Cabioglu 
et al[20] performed a study to determine whether CXCR4, 
CCR7, ER, PR and HER2-neu in metastatic breast cancer 
were expressed in some organ-specific metastasis, and they 
found that CXCR4 can promote primary breast cancer to 
have bone metastasis. There are more and more studies on 
CXCR4 at present, and the targeted therapy to CXCR4 would 
be a new hot spot on gene therapy of tumors.   
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